המוסול B0
Country: Iżrael
Lingwa: Ebrajk
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
CALCIUM CHLORIDE DIHYDRATE; LACTIC ACID; MAGNESIUM CHLORIDE HEXAHYDRATE; SODIUM CARBONATE HYDROGEN; SODIUM CHLORIDE
Disponibbli minn:
BAXTER HEALTHCARE DISTRIBUTION LTD., ISRAEL
Kodiċi ATC:
B05XA30
Għamla farmaċewtika:
תמיסה להמופילטרציה
Kompożizzjoni:
CALCIUM CHLORIDE DIHYDRATE 5.145 G / 1000 ML; MAGNESIUM CHLORIDE HEXAHYDRATE 2.033 G / 1000 ML; LACTIC ACID 5.400 G / 1000 ML; SODIUM CHLORIDE 6.45 G / 1000 ML; SODIUM CARBONATE HYDROGEN 3.090 G / 1000 ML
Rotta amministrattiva:
לשימוש עם מכשירי המודיאליזה
Tip ta 'preskrizzjoni:
מרשם נדרש
Manifatturat minn:
BIEFFE MEDITAL S.P.A., ITALY
Grupp terapewtiku:
COMBINATIONS OF ELECTROLYTES
Żona terapewtika:
COMBINATIONS OF ELECTROLYTES
Indikazzjonijiet terapewtiċi:
As substitution solution in continuous haemofiltration and haemodiafiltration and as dialysis solution in continuous haemodialysis for acute renal failure.
Data ta 'l-awtorizzazzjoni:
2013-10-31
